Find your path to Ayman
154 people in our graph share verified history with Ayman — schools, employers, funds. One of them is your warm intro.
Richard HeymanunlockedAyman: together at Kalypsys Inc. (2006–2008)
×4Ayman: together at Monsanto Company
Ayman: together at Solstice Biologics
×2Ayman: together at University of Massachusetts Lowell
Executive at Wugen
Intro paths
→
In turn, Ayman can intro founders to Wugen's investors below.
Wugen's investors · 8
AbingworthLondon · $15M – $30M checks · since 2020Aisling CapitalNew York · since 2025Alpha Wave GlobalMiamiBioGenerator VenturesSt. Louis · $50K – $250K checksFidelity InvestmentsBoston · since 2025Intermediate Capital GroupLondon · $5M – $50M checks · since 2025LYZZ CapitalShanghai · since 2025RiverVest Venture PartnersSt. Louis · $500K – $3M checks · since 2021
Experience
- Allotera Therapeutics (formerly Wugen)Chief Operating Officer, Executive Vice President of Research & Developmentcurrent2021 — presentSan Diego, CA
- Allotera Therapeutics (formerly Wugen)Senior Vice President, Head of Research & Development2018 — 2021
- OxaluRx Inc.Chief Scientific Officer2018 — 2021
- Tallac TherapeuticsCo-Founder & Vice President of Biology2018
- Solstice Biologics LLCExecutive Director, Head of Biology & Pharmacology2016 — 2017San Diego, California, United States
- Solstice Biologics USA Inc.Senior Director, Head of Biology & Pharmacology2013 — 2016San Diego, California, United States
- Traversa Therapeutics, IncHead of Biology & Pharmacology2010 — 2012San Diego, California, United States
- Kalypsys Inc.Head of Pharmacology2008 — 2009San Diego, California, United States
- Kalypsys IncPrincipal Scientist2006 — 2008
- Kalypsys Inc.Senior Scientist2004 — 2006
- PfizerSenior Scientist2000 — 2004
- Monsanto CompanyResearch Scientist1998 — 2000
- Harvard Medical School and Massachusetts General HospitalMedical Technologist (Part time)1992 — 1998
Skills & more
PharmacologyDrug DiscoveryBiotechnologyLifesciencesBiochemistryDrug DevelopmentProtein ChemistryChemistryMolecular BiologyAssay DevelopmentCommercializationCell Biology
From Ayman's professional profile.
Frequently asked questions
- Who is Ayman Kabakibi?
- Executive Officer at Wugen
- Where does Ayman Kabakibi work?
- Ayman Kabakibi is Executive at Wugen.
- Where did Ayman Kabakibi go to school?
- Ayman Kabakibi studied at University of Massachusetts Lowell (Ph.D., Biochemistry); Northeastern University (M.S., Medical Laboratory Sciences/Medical Technology); Damascus University (B.Sc., Pharmacy).
Same school
Also attended University of Massachusetts Lowell48
Chris RustCo-Founder and Partner at Clear VenturesSamar JahanVice President of Finance at Mission BiocapitalAudrey Hernon GuzasIT Manager at HLM Investment PartnersSatoshi KonagaiInvestment Lead at Astellas Venture Management LLCLeo CaseyHead of Republic of Ireland at Business Growth FundJeremy AchinGeneral Partner at Cortical Ventures
+ 42 more
Also attended Northeastern University477
Matt GuineyChief Financial Officer at Flybridge Capital PartnersAllison KuziwGlobal Human Resources Executive at Marlin Equity PartnersSaunaz MoradiPartner, Communications at Lux CapitalBrian DixonManaging Partner at Kapor CapitalMurat BicerGeneral Partner at CRV (Charles River Ventures)Christopher WolfChief Financial Officer at MPM BioImpact
+ 471 more
Shared employers
Also worked at Tallac Therapeutics2
Also worked at Kalypsys Inc.2
Also worked at Pfizer402
Jigar RaythathaInvestor at Third Rock VenturesAbbie CelnikerInvestor at Third Rock VenturesErin MooreInvestor at Third Rock VenturesJeb KeiperInvestor at Third Rock VenturesRichard ChesworthInvestor at Third Rock VenturesMichael TaylorOperating Partner at Mission Biocapital
+ 396 more
Also worked at Monsanto Company76
Andrew AbramsPartner at NSVRick RyanGeneral Partner at Cultivation CapitalMartha SchlicherGeneral Partner at Cultivation CapitalGanesh KishoreInvestor at Spruce Capital PartnersNick RosaInvestor at Sandbox IndustriesChas EggertOperating Partner at iSelect Fund
+ 70 more